Vista Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

7.51

7.36

7.36

6.07

6.07

Share application money

-

-

-

-

2.48

Preference share capital

-

-

-

-

-

Reserves & surplus

29.20

28.09

25.49

23.57

27.25

Loan funds

Secured loans

9.96

12.55

14.98

15.47

11.17

Unsecured loans

-

-

-

-

-

Total

46.67

48.00

47.82

45.11

46.97

Uses of funds

Fixed assets

Gross block

26.76

25.74

25.72

25.72

24.24

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

7.02

6.41

5.79

5.06

3.71

Net block

19.74

19.33

19.93

20.66

20.52

Capital work-in-progress

9.33

9.08

9.08

8.78

8.54

Investments

0.02

0.03

0.04

0.02

0.03

Net current assets

Current assets, loans & advances

26.95

27.14

21.80

21.66

23.66

Less : current liabilities & provisions

9.36

7.59

3.03

6.01

5.79

Total net current assets

17.58

19.56

18.77

15.65

17.87

Miscellaneous expenses not written

-

-

-

-

-

Total

46.67

48.00

47.82

45.11

46.97

Notes:

Book value of unquoted investments

-

0.03

0.04

0.02

-

Market value of quoted investments

0.02

-

-

-

-

Contingent liabilities

-

-

-

-

3.99

Number of equity sharesoutstanding (Lacs)

375.57

367.94

367.94

303.65

303.65